SAN DIEGO – Resmed has a new collaboration with 23XI Racing and its NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment. After being diagnosed with obstructive sleep apnea (OSA) and starting continuous positive airway pressure (CPAP) therapy in early 2026, Reddick went on to become the first driver in NASCAR Cup Series history to open a season with three consecutive victories, which included the Daytona 500. The company says his experience highlights the performance advantage that treating his sleep apnea can provide. “Looking back, I had sleep apnea symptoms for a long time, but I didn’t think it was something that could affect me,” said Reddick. “I noticed a difference after night one of using my Resmed CPAP therapy, and it completely changed the way I approach recovery, preparation and performance. I’ve realized that a competitive edge is built through the habits you commit to every day, and prioritizing my sleep health has become one of the most important. If sharing my experience helps someone else recognize the signs and take action, that’s a win.” Throughout the remainder of the 2026 NASCAR season, Resmed and Reddick will share sleep health education through his personal journey with sleep apnea, encouraging more people to recognize the signs and understand the role sleep plays in recovery and performance. Resmed branding will also be present on track with 23XI on Reddick’s No. 45 Toyota Camry XSE at NASCAR Cup Series races at Bristol Motor Speedway on Sept. 19, Talladega Superspeedway on Oct. 25 and Homestead-Miami Speedway on Nov. 8.
Photo courtesy of Resmed
